Manual vs. Automated moNitoring Accuracy of GlucosE (MANAGE)
- Conditions
- Critical illness associated hyperglycemia10018424
- Registration Number
- NL-OMON34611
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 75
* Informed consent.
* Age > 18 years.
* Admitted to the ICU of the Academic Medical Center.
* Expected ICU stay of * 3 days at the time of enrolment (as judged by Principle Investigator).
* APACHE II score of * 10.
* Existing central venous catheter + arterial catheter.
* No participating in any other investigational interventional study while enrolled in this study.
* Have received any investigational product or been treated with an investigational device within the past 30 days.
* Pregnancy.
* Untreatable colonization with multi*resistant bacteria (e.g., methicillin*resistant Staphylococcus aureus).
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>* Glucose prediction error, defined as [the YSI (the gold standard) versus<br /><br>the OptiScanner result, as well as all other measurement technologies used on<br /><br>central venous blood].<br /><br>* Clarke Error Grid analysis between the YSI and the OptiScanner result, to<br /><br>show the percentage of paired data values falling within each zone.<br /><br>* Linearity between the YSI and the OptiScanner, as well as all other<br /><br>measurement technologies used on central venous blood.</p><br>
- Secondary Outcome Measures
Name Time Method <p>* Glucose prediction error, defined as [the YSI versus all other measurement<br /><br>technologies used on arterial blood].<br /><br>* Clarke error grid analysis between the YSI and all other measurement<br /><br>technologies used on arterial blood.<br /><br>* Linearity between the YSI and all other measurement technologies used on<br /><br>arterial blood.</p><br>